Category Archives: "INforMS"

FDA approves Zeposia (Ozanimod), oral therapy for all with relapsing multiple sclerosis
The U.S. Food and Drug Administration (FDA) has approved Zeposia (ozanimod) oral capsules to treat adults with relapsing forms [...]
MedDay report top-line data from trial “SPI2” for treatment of progressive forms of multiple sclerosis
Paris, France, March 10, 2020 – MedDay Pharmaceuticals announced today that the second pivotal Phase III trial (SPI2) of its [...]
U.S. health officials urge Americans to prepare for spread of Coronavirus
CHICAGO/WASHINGTON (Reuters) - The U.S. Centers for Disease Control and Prevention (CDC) on Tuesday alerted Americans to begin preparing [...]
Participate in a study evaluating a potential treatment options for RRMS relapses
The OPTIONS Study is looking at how well a study drug works for adults with relapsing-remitting multiple sclerosis (RRMS) who are currently [...]
Brain activity patterns linked with improved learning and memory in multiple sclerosis
A recent article by Kessler Foundation researchers demonstrated g people with multiple sclerosis (MS). The article, "Brain activation [...]
Robotic ‘trousers’ could help thousands of multiple sclerosis sufferers stand and walk again
Robotic ‘trousers’ could help thousands of people left unable to stand or walk due to multiple sclerosis find their feet again. The [...]
Use of DMTs changing ‘natural history’ of relapsing multiple sclerosis, study says
People with relapsing multiple sclerosis (MS) have a better prognosis and a slower progression to disability since the introduction of [...]
FDA approves first generics for common multiple sclerosis drug
The FDA has approved 3 applications for generics of fingolimod (Gilenya, Novartis). These are the first generics of the drug, which treats [...]
Results for Genentech’s Satralizumab in Neuromyelitis Optica Spectrum
Satralizumab demonstrated robust efficacy, sustained for 144 weeks, in significantly reducing the risk of relapse in combination with [...]
NeurologyLive™ adds CMSC to its Strategic Alliance Partnership program
CRANBURY, N.J.--(BUSINESS WIRE)--NeurologyLive™, a multimedia platform dedicated to providing health care professionals treating [...]

CMSC provides leadership in clinical research and education; develops vehicles to share information and knowledge among members; disseminates information to the health care community and to persons affected by MS.

Contact Us
Contact Us
I have a question about
First
Last